新发帕金森病言语亚型的定义:对长期左旋多巴治疗的反应
本研究对111例新发帕金森病患者进行言语声学分析,用无监督k-means聚类识别出韵律型、发声-韵律型和构音-韵律型三种言语亚型。83例完成12个月随访,结果显示长期多巴胺能药物可维持韵律型和构音-韵律型言语损害稳定,并改善发声-韵律型言语表现。
要点
- 新发帕金森病可聚类为韵律型、发声-韵律型和构音-韵律型三种言语亚型。
- 构音-韵律型以男性、年龄较大、轴性步态症状重和认知较差为特征。
- 发声-韵律型经长期多巴胺能药物治疗后言语表现改善(p=0.002)。
核心结论
- 新发帕金森病存在三种 distinct 言语表型,反映不同潜在机制,并可预测言语损害对左旋多巴治疗的反应。
研究设计与样本
- 研究纳入111例新发帕金森病患者,其中83例完成12个月随访(69例接受稳定多巴胺能药物治疗,14例未治疗对照)。
- 对8项量化声学分析的少动性构音障碍参数进行无监督k-means聚类分析。
主要发现
- 检测到三种言语亚型:韵律型、发声-韵律型和构音-韵律型,三者患病率、症状持续时间和运动严重程度相似。
- 除单音调和单响度在各亚型中常见外,发声-韵律型以发声障碍为主,构音-韵律型以辅音构音不精确为主,两者言语损害均重于韵律型。
- 韵律型以女性和较年轻年龄为特征;构音-韵律型以男性、年龄较大、轴性步态症状更重和认知表现更差为特征。
- 发声-韵律型临床表现为年龄居中、以男性为主且认知表现保留。
- 未治疗对照帕金森病患者言语在1年内恶化(p=0.02)。
关键数值与推荐
- 长期多巴胺能药物使韵律型和构音-韵律型言语损害严重程度保持稳定。
- 长期多巴胺能药物改善发声-韵律型患者的言语表现(p=0.002)。
临床怎么用
- 对新发帕金森病伴言语损害患者,言语表型与左旋多巴反应相关,可据此预判疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patterns of speech disorder in Parkinson disease (PD), which are highly variable across individual patients, have not been systematically studied. Our aim was to identify speech subtypes in treatment-naive patients with PD and to examine their response to long-term dopaminergic therapy. METHODS: We recorded speech data from a total of 111 participants with de novo PD; 83 of the participants completed the 12-month follow-up (69 patients with PD on stable dopaminergic medication and 14 untreated controls with PD). Unsupervised k-means cluster analysis was performed on 8 distinctive parameters of hypokinetic dysarthria examined with quantitative acoustic analysis. RESULTS: Three distinct speech subtypes with similar prevalence, symptom duration, and motor severity were detected: prosodic, phonatory-prosodic, and articulatory-prosodic. Besides monopitch and monoloudness, which were common in each subtype, speech impairment was more severe in the phonatory-prosodic subtype with predominant dysphonia and the articulatory-prosodic subtype with predominant imprecise consonant articulation than in the prosodic subtype. Clinically, the prosodic subtype was characterized by a prevalence of women and younger age, while articulatory-prosodic subtype was characterized by the prevalence of men, older age, greater severity of axial gait symptoms, and poorer cognitive performance. The phonatory-prosodic subtype clinically represented intermediate status in age with mostly men and preserved cognitive performance. While speech of untreated controls with PD deteriorated over 1 year (p = 0.02), long-term dopaminergic medication maintained stable speech impairment severity in the prosodic and articulatory-prosodic subtypes and improved speech performance in patients with the phonatory-prosodic subtype (p = 0.002). DISCUSSION: Distinct speech phenotypes in de novo PD reflect divergent underlying mechanisms and allow prediction of response of speech impairment to levodopa therapy. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that, in patients with newly diagnosed PD with speech impairment, speech phenotype is associated with levodopa responsiveness.
引用
- Rusz J, Tykalova T, Novotny M, et al. Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy. Neurology. 2021. PMID: 34607922. doi:10.1212/WNL.0000000000012878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。